Antibodies Discussed | ||
Antibody Symbol/Name | Antibody Description | Clones/Alternative Names |
β-2-microglobulin | component of MHC class I molecules | B2-MICROGLB |
κ light chain | kappa light chain | KAPPA |
λ light chain | lambda light chain | LAMBDA |
Actin-HHF-35 | actin, muscle (HHF35) | MSA, HHF-35 |
Actin-sm | actin, smooth muscle | SMA, ASM-1, CGA7, IA4, HUC-1 |
AE1/AE3 | AE1/AE3; mixture of 2 anticytokeratin clones that detect a variety of both high and low molecular weight cytokeratins | |
ALK1 | anaplastic lymphoma kinase-1 | SA4, ALK, ALKC |
Androgen receptor | dihydrotestosterone receptor, nuclear subfamily 3, group C, member 4 | AR441, F39.4.1, AR-N20, AR27 |
Annexin-A1 | mediator of anti-inflammatory response and upregulated in hairy cell leukemia | ANXA1, LPC1, lipocortin |
BAD | bcl-2-associated agonist of cell death | |
Bartonella henselae | B. henselae | B-henselae, cat scratch fever agent |
BAX | bcl-2-associated X protein | PU-347-P, B-9, BAX-P, P19, BAX-M |
Bcl-2 | B-cell CLL lymphoma 2; suppresses apoptosis in a variety of cell systems | ONCL2, BCL2/100/D5, 124, 124.3 |
Bcl-6 | B-Cell CLL lymphoma 6 | LN22, GI191E/A8, N-3, PG-B6P, P1F6, 3FR-1 |
BDCA-2 | Monoclonal antibody directed toward immature plasmacytoid dendritic cells | CD303 |
BF1 | T-cell antigen receptor | TCR |
BOB1 | B-cell OCT-binding protein 1 | SC955, BOB.1 |
Caldesmon | actin interacting and calmodulin binding protein found in smooth muscle and other cell types | CAD, CALD1, caldesmon 1 isoform [1-5], CDM, HCAD, LCAD, MGC21352, NAG22 |
CD1a | T-cell surface glycoprotein | JPM30, CD1A, O10, NA1/34 |
CD2 | T-cell surface antigen, LFA2 | 271, MT910, AB75, LFA-2 |
CD2AP | CD2 associated protein | |
CD3 | T-cell receptor | F7238, A0452, CD3-P, CD3-M, SP7, PS1 |
CD3-ε | T cell surface antigen T3/Leu-4 epsilon chain | CD3E, CD03e |
CD4 | T-cell surface glycoprotein L3T4 | IF6, 1290, 4B12 |
CD5 | T-cell surface glycoprotein Leu 1, T1 | NCL-CD5, 4C7, 54/B4, 54/F6 |
CD7 | T-cell antigen precursor Leu 9 | 272, CD7-272 |
CD8 | T-cell coreceptor antigen, Leu 2, T-cytotoxic cells | M7103, C8/144, C8/144B |
CD10 | neutral endopeptidase | CALLA, neprilysin, NEP |
CD11c | integrin alpha X chain protein | LEU-M5 |
CD12 | CDw12 | |
CD13 | plays role in growth of DC/macrophage progenitors and precursors | |
CD15 | reacts with Reed-Sternberg cells of Hodgkin disease and with granulocytes | VIM-2,3C4, LEU-M1, TU9, VIM-D5, MY1, CBD1, MMA, 3CD1, C3D1, Lewis x, SSEA-1 |
CD16 | Fc receptor of IgG | |
CD19 | B-cell antigen | |
CD20 | membrane spanning 4 domains of B-lymphocytes | FB1, B1, L26, MS4A1 |
CD21 | CR2, complement component receptor 2, Epstein-Barr virus receptor | IF8 |
CD22 | B-cell receptor | FPC1, LEU 14 |
CD23 | Fc ∈ RII, low-affinity IgE receptor, | IGEBF 1B12, MHM6BU38 |
CD25 | If-2 receptor alpha | 2A3, 4C9 |
CD26 | ADA adenosine deaminase complexing protein 2, DPP4 | 44-4 |
CD27 | TNF receptor | |
CD29 | fibronectin receptor, integrin beta 1 ITGB1 | 29C03, 7F10, HT29_12938 |
CD30 | tumor necrosis factor SF8 | BER-H2, KI-1, TNFRSF8 |
CD31 | platelet endothelial cell adhesion molecule | JC/70, JC/70A, PECAM-1 |
CD33 | SIGLEC lectin 3 | PWS44 |
CD34 | hematopoietic progenitor cell antigen | MY10, IOM34, QBEND10, 8G12, 1309, HPCA-1, NU-4A1, TUK4, clone 581, BI-3c5 |
CD35 | erythrocyte complement receptor 1, immune adherence receptor, C3b/C4b receptor | CR1, BER-MAC-DRC, TO5C, E11 |
CD38 | acute lymphoblastic T-cell antigen, T10 | SPC32, VS38, T10 |
CD43 | Major sialoglycoprotein on surface of human T lymphocytes, monocytes, granulocytes, and some B lymphocytes | LEU-22, DF-T1, L60, MT1, sialophorin, leukosialin, SPN |
CD44 | cell adhesion receptor for hyaluronic acid HCAM | 9B5, HCAM, CD44H, B-F24, A3D8, 2C5, CD44S, F10-44.2, 156-3C11, DF1485, BBA10, VFF-14, CD44V10, CD44V3, 3G5, CD44V3-10-P, CD44V3-10, 3D2, CD44V4_5, CD44V5, VFF-8, VFF-7, 2F10, VFF-18, CD44V6, CD44V7, VFF-9, CD44V7_8, VFF-17 |
CD45 | leukocyte common antigen | LCA, PD7/26, 1.22/4.14, T29/33, RP2/18, PD7, 2D1, 2B11+PD7/26 |
CD45RA | isoform of CD45 expressed by naive T cells | 4Kb5, MT2, MB1 |
CD45RO | isoform of CD45 located on memory T cells | ICH1-L, low molecular weight isoform LCA |
CD54 | ICAM-1 (intracellular adhesion molecule 1) | 23G12, CD54-P, ICAM |
CD56 | NCAM (neutral cellular adhesion molecule) | MAB735, ERIC-1, 25-KD11, 123C3, 24-MB2, BC56C04, 1B6, 14- MAB735, NCC-LU-243, MOC-1, NCAM |
CD57 | β-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) | LEU-7, NK1, HNK-1, TB01, B3GAT1 |
CD68 | cytoplasmic granule protein of monocytes, macrophages | PG-M1, KP-1, LN5 |
CD72 | B-cell differentiation antigen | DBA.44 |
CD79-α | immunoglobulin-associated alpha, MB1 | MB-1, 11D10, 11E3, CD79A, HM47/A9, HM57, JCB117 |
CD103 | ||
CD117 | C-kit; tyrosine protein kinase activity | C-19 (C-KIT), 104D2, 2E4, C-KIT, A4502, H300, CMA-767 |
CD123 | receptor for IL-3 (IL-3R) | |
CD138 | syndecan; a useful marker for plasma cells | B-B4, AM411-10M, MI15 |
CD163 | macrophage hemoglobin scavenging system | 10D6 |
CD303 | monoclonal antibody directed toward immature plasmacytoid dendritic cells | BDCA-2 |
CEA-M | carcinoembryonic antigen, monoclonal | CEA-B18, CEA-D14, CEA-GOLD 1, T84.6, CEA-GOLD 2, CEA 11, CEA-GOLD 3, CEA 27, CEA-GOLD 4, CEA 41, CEA-GOLD 5, T84.1, CEA-M, A5B7, CEJ065, IL-7, T84.66, TF3H8-1, 0062, D14, alpha-7, PARLAM 1, ZC23, CEM010, A115, COL-1, AF4, 12.140.10, 11-7, M773, CEA-M431_31, CEJO65, mCEA |
Centerin | Serine proteinase inhibitor A11 antibody. May play an important role in GC-B cell physiology; expression in lymphomas can be important in differential diagnosis | GCET1, seprin A9, Serpina 11b, Serpina9 |
CK-PAN | cytokeratin-pan (AE1/AE3/LP34); cocktail of high and low molecular weight cytokeratins | keratin pan, MAK-6, K576, LU-5, KL-1, KC-8, MNF 116, pankeratin, pancytokeratin |
CK20 | Cytokeratin 20, low molecular weight cytokeratin with expression most commonly restricted to GI tract | KS20.8 |
CLA | cutaneous lymphocyte antigen | CLA-HECA452 |
Clusterin | clusterin, alpha chain specific | 41D, E5 |
CMV | cytomegalovirus | |
CRP | c-reactive protein | |
CTLA-4 | cytotoxic T-lymphocyte antigen 4 | BN13 |
CXCL13 | chemokine CXC ligand 13 | 53610, B lymphocyte chemoattractant (BLC) |
CXCR3 | chemokine CXC receptor R3 | 1C6 |
Cyclin-D1 | Protein with important cell cycle regulatory functions; proto-oncogene; regulator of cell cycle progression (G1 to S-phase) | A-12, PRAD1, AM29, DCS-6, SP4, 5D4, D1GM, P2D11F11 |
Cyclin E | key regulator of G/S transition in cell cycle; overexpression observed in several malignancies associated with high proliferation | 13A3, HE12 |
D11 | homeobox D11 | HOXD11 |
DBA.44 | CD72, B-cell differentiation antigen | CD72 |
Desmin | class III intermediate filaments found in muscle cells | M760, DE-R-11, D33, DE5, DE-U-10, ZC18 |
E2A | immunoglobulin enhancer-binder factor E12/E47 | |
EBER | Epstein-Barr virus encoded RNA | |
EBNA2 | Epstein-Barr virus-associated nuclear antigen 2 | |
EBV-LMP | Epstein-Barr virus latent membrane protein | LMP1, CS 1-4 |
EBV-LMP1 | viral protein produced during latent cycle of EBV infection | |
EGFR | v-erb b1 erythroblastic leukemia viral gene, epidermal growth factor receptor | 2-18C9, EGFR1, EGFR PHRMDX, NCL-R1, H11, C-ERBB-1, E30, EGFR.113, 31G73C6, 2-18C9 |
EMA | epithelial membrane antigen | GP1.4, 214D4, MC5, E29, MUC1, EMA/MUC1 |
Factor XIIIa | factor-XIIIA (fibrin stabilizing factor) | FXIIIA |
FAS | CD 95 (Fas receptor (FasR) | CD95, fatty acid synthase, APO-1, UB2, B10 |
Fascin | singed-like protein | 55K2, FAN1, Fascin 1, FSCN1, p55, SNL, singed like protein antibody |
FOXP1 | forkhead box transcription factor P3 | JC12 |
GZM-B | Granzyme B; neutral serine protease | 11F1, GR-B7, Granzyme B |
H-caldesmon | high molecular weight caldesmon | HCAD, H-CD |
Helicobacter pylori | H. pylori | H-pylori |
HGAL | human germinal center-associated lymphoma | |
HHV8 | human herpesvirus-8 latent nuclear antigen-1 | 13B10, LNA-1, Kaposi sarcoma associated herpes virus, KSHV |
HLA-DR | human leukocyte antigen DR | DK22, LN3, TAL.1B5, LK8D3 |
HMB-45 | antigen present in melanocytic tumors such as melanomas | LB39 AA, CMM1, CMM, DNS, FAMMM, Mart1, Melan-A, MLM, tyrosinase |
HPV | human papillomavirus | |
HSV1/2 | herpes simplex virus 1/2 | HSV1/HSV2 |
ID2 | DNA binding protein inhibitor | |
IgA | immunoglobulin A | IGA |
IgD | immunoglobulin D | IGD |
IgM | immunoglobulin M | IGM |
IL-13 | interleukin 13 | |
IRF-4 | interferon regulatory factor 4 | MUM1P, clone MUM1, MUM1-IRF.4, MUM1, M17 |
J chain | immunoglobulin joining segment | NFGD11 |
Ki-67 | Ki-67 (MIB-1); marker of cell proliferation | MMI, KI88, IVAK-2, MIB1 |
L1 | neural adhesion molecule | UJ127, CD171 |
LANA1 | latency associated nuclear antigen of HHV8 | Human herpes 8 latent nuclear antigen, LN53 |
Langerin | CD207 molecule | CD207 |
LCA | leukocyte common antigen | PD7/26, 1.22/4.14, T29/33, CD45RB, RP2/18, CD45, PD7, 2D1, 2B11+PD7/26 |
LMP1 | Epstein Barr virus- latent membrane protein | EBV-LMP, CS 1-4 |
Lysozyme | 1,4-beta N-acetylmuramidase C | Lyz, Lzm, Ec3.2.1.17 |
M1 | gastric superficial/foveolar cells | |
M2 | Cyclin dependent kinase 2 | CDK2 |
Melan-A | melanoma antigen recognized by T cells 1 (MART-1); protein found on melanocytes; melanocyte differentiation antigen | M2-7C10, CK-MM |
Melan-A103 | clone of Melan-A | A103 |
met | met protooncogene | 8F11, C-28, C-MET |
MK | neurite growth promoting factor 2 | Midkine, G2a, |
MPO | myeloperoxidase | |
MT | metallothionein | Clone E9 |
Mucosal homing receptor | role in lymphocyte homing to mucosal lymphoid tissues | Integrin-α4β7 |
MUM1 | Interferon regulatory factor 4 | IRF-4, MUM1P, clone MUM1, MUM1-IRF.4, M17 |
MxA | Protein induced by alpha interferon protein | |
Myosin | motor protein responsible for actin-based motility | |
N3 | calponin | calponin, calp |
NOTCH1 | translocation-associated notch protein | |
p16 | cyclin-dependent kinase 4 inhibitor 2A | P16_INK4A, E6H4, sc1661, JC8, JZ11, P16, G175-405, F-12, DCS-50, 6H12, 16P07, 16P04 |
p21 | cyclin-dependent kinase inhibitor 1A | WAF1, DCS-60.2, EA10, 6B6, 4D10, SX118, P21, P21_WAF1, WAFT |
p53 | p53 tumor suppressor gene protein | DO7, 21N, BP53-12-1, AB6, CM1, PAB1801, DO1, BP53-11, PAB240, RSP53, MU195, P53 |
p63 | tumor protein p63 | H-137, 7JUL |
pax-5 | paired box gene 2 | Z-RX2, PAX-2 |
PD-1 | programmed cell death protein 1 | EH12, NAT105, Programmed death 1 |
Perforin | P1-8, PE-41-PU, 5B10 | |
PR | progesterone receptor | 10A9, PGR-1A6, KD68, PGR-ICA, PRP-P, PRP, PRI, 1A6, 1AR, HPRA3, PGR-636, 636, PR88, NCL-PGR |
PU.1 | transcription factor PU.1 | G148-74 |
S100 | Low molecular weight protein normally present in cells derived from neural crest (Schwann cells, melanocytes, and glial cells), chondrocytes, adipocytes, myoepithelial cells, macrophages, Langerhans cells, dendritic cells, and keratinocytes | S-100, A6, 15E2E2, Z311, 4C4.9, S100 protein |
TCL1 | trophoblast membrane protein 1 | NDOG1 |
TCR | T-cell receptor antigen | T_Cell_AG_R, Beta-F1, 8A3, BF1 |
TCR-αβ | T-cell receptor heterodimer composed of an alpha and a beta chain | |
TCR-β | Antibody directed toward the beta chain of the TCR-αβ heterodimer | |
TCR-γ | T-cell receptor gamma chain | TCR-gamma |
TCR-γδ | T cell receptor heterodimer composed of a gamma and a delta chain | |
TdT | terminal deoxynucleotidyl transferase | SEN28 |
TF | Thomasen-Friedenreich blood group antigen | HB-T1 |
Thyroglobulin | dimetric protein specific to thyroid gland | DAK-TG6 |
TIA | T-cell intracellular antigen 1 | NS/1-AG4, 2G9, TIA-1 |
TNF-α | Antibody directed toward the alpha chain of the TCR-αβ heterodimer | |
TRAF1 | tumor necrosis factor receptor 1 | |
TRAP | tartrate-resistant acid phosphatase | 26E5, 9C5 |
Tryptase | serine proteinase contained in mast cells | AA1 |
Tyrosinase | catalyzes production of melanin | NCL-TYROS, T311 |
VEGF | vascular endothelial growth factor | JH121, 26503.11, VPF, VPF/VEGF, VEGF-A, VEGF-C, RP 077, VEGFR-1, RP 076, VEGFR-2, 9D9, VEGFR-3, FLT-4 |
Vimentin | major subunit protein of intermediate filaments of mesenchymal cells | 43BE8, 3B4, V10, V9, VIM-B34, VIM |
VS38 | type II transmembrane glycoprotein expressed on many types of immune cells (i.e., activated T-cells, precursor and activated B-cells, plasma cells, monocytes, peripheral NK -cells, and early bone marrow precursor cells) | CD38, SPC32, VS38, T10 |
WT1 | Wilms tumor gene 1 | 6F-H2, C-19 |
ZAP70 | SYK-ZAP-70 protein | 2F3.2, ZAP-70, ZAP-70-LR |
Antibody Index
Antibody Index